Adjustments can be made as needed
The most commonly reported adverse effects in Phase 2 trials were gastrointestinal in nature, including: Nausea (the most frequently reported) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally dose-dependent and most pronounced during dose escalation, typically improving over time
Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M
Computerized neuropsychological measures and remote digital monitors are increasingly available and may offer insights into drug effects not available from other measures [123,124,125]
taking these drugs could grow from around 2 million today to 15 million in 2030, Goldman Sachs analyst Chris Shibutani writes in a report, increasing the size of the GLP-1 market from $10 billion to $100 billion in 2030
Mona te na bieco ledzi informacje o dostpnoci w innych aptekach w Polsce (tutaj) to czsto pomaga szybciej znale potrzebny preparat